CLNN Form 4: Director Jonathon Gay receives 4,790 immediately vested options
Rhea-AI Filing Summary
Clene Inc. (CLNN) reported a Section 16 Form 4 showing that director Jonathon Gay was granted a stock option on 08/14/2025 for 4,790 shares of common stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The filing states the options vest immediately upon grant.
The derivative instrument lists an expiration (or date referenced) of 08/13/2035. The Form 4 was signed by a power of attorney, Jerome T. Miraglia, on 08/15/2025. The report shows the acquisition was an option grant and indicates the number of underlying shares and exercise price but does not disclose total company holdings or percentage ownership after the grant.
Positive
- Immediate vesting aligns the director's interests with shareholders without future service conditions
- Clear disclosure of grant date, option quantity, and exercise price provides transparency of insider activity
Negative
- Potential dilution from the issuance of 4,790 options, although the filing does not state the percentage impact on outstanding shares
Insights
TL;DR: Director received a small, immediately vested option grant—informative for insider alignment but likely not material to valuation.
The Form 4 documents an option award of 4,790 shares at a $3.60 exercise price that vests immediately. From a securities perspective, this is a routine equity compensation event used to align management and directors with shareholder interests. The immediate vesting removes future service conditions, accelerating potential insider exposure to stock price movements. The filing lacks context on total outstanding shares or the grant's percentage dilution, so materiality cannot be determined from the document alone.
TL;DR: Immediate-vesting option for a director signals retention/compensation action but raises governance questions about timing and approval.
The disclosure shows an option grant under the 2020 plan with immediate vesting, which can be standard but sometimes invites scrutiny if timing aligns with corporate events. The Form 4 is properly filed and signed by POA. Key governance context—such as board approval details, grant rationale, and impact on dilution—is not included in this filing, so assessment of governance best practices is limited by the document's scope.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | stock option | 4,790 | $0.00 | -- |
Footnotes (1)
- [object Object]
